ClassID:

96729

C07K5/1027 - CPC Classification

Classification description:

Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides containing heteroatoms different from O, S, or N

Recent Application in this class:
#1
20250059231
2025-02-20

Protease inhibitors

#2
20230357318
2023-11-09

Solution phase synthesis of β-turn peptidomimetic cyclic salts

#3
20230128167
2023-04-27

OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF

#4
20220112239
2022-04-14

PROCESS AND INTERMEDIATES FOR SYNTHESIS OF PEPTIDE COMPOUNDS

#5
20210330712
2021-10-28

Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells

#6
20210300966
2021-09-30

Solution phase synthesis of beta-turn peptidomimetic cyclic salts

#7
20210230220
2021-07-29

Methods for the synthesis of arginine-containing peptides

#8
20210230218
2021-07-29

OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF

#9
20190223814
2019-07-25

18F labeled amino acids, derivatives thereof and method of making same

#10
20190194251
2019-06-27

Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

#11
20190135863
2019-05-09

Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells

#12
20190046582
2019-02-14

Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells

#13
20180155395
2018-06-07

Peptidomimetics for imaging the ghrelin receptor

#14
20170342107
2017-11-30

Melanocortin ligands and methods of use thereof

#15
20170008923
2017-01-12

Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

#16
20150218212
2015-08-06

FLUORINATED EPOXYKETONE-BASED TETRAPEPTIDE COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS

#17
20150174197
2015-06-25

Peptoids useful for the mineralization of apatite

#18
20130303435
2013-11-14

Smart pro-drugs of serine protease inhibitors

#19
20130149240
2013-06-13

99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS

#20
20130144036
2013-06-06

Quinoxaline-containing compounds as hepatitis C virus inhibitors

#21
20130012430
2013-01-10

INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE

#22
20120258550
2012-10-11

REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF

#23
20110312875
2011-12-22

Peptidic compounds

#24
20110263817
2011-10-27

METAL-BINDING COMPOUNDS AND USES THEREFOR

#25
20110229568
2011-09-22

Michael systems as transglutaminase inhibitors

#26
20110212903
2011-09-01

Metal-binding compounds and uses therefor

#27
20110212902
2011-09-01

Metal-binding compounds and uses therefor

#28
20110104115
2011-05-05

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#29
20100249016
2010-09-30

Metal-binding compounds and uses therefor

#30
20100173851
2010-07-08

INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE

#31
20100168032
2010-07-01

Smart Pro-Drugs of Serine Protease Inhibitors

#32
20100144644
2010-06-10

Metal-binding compounds and uses therefor

#33
20100092458
2010-04-15

REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF

#34
20100086541
2010-04-08

Regulation of autophagy pathway phosphorylation and uses thereof

#35
20100003214
2010-01-07

Quinoxaline-containing compounds as hepatitis C virus inhibitors

#36
20090220419
2009-09-03

99m Tc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors

#37
20090197888
2009-08-06

Fluorinated tripeptide HCV serine protease inhibitors

#38
20090163696
2009-06-25

METHOD FOR PREPARING LYSOBACTIN DERIVATIVES

#39
20090143312
2009-06-04

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

#40
20080311079
2008-12-18

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#41
20080300287
2008-12-04

Peptidic compounds

#42
20080176806
2008-07-24

Therapeutic uses of tri-, tetra-, penta-, and polypeptides

#43
20080045480
2008-02-21

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#44
20070292933
2007-12-20

Inhibitors of serine proteases, particular HCV NS3-NS4A protease

#45
20070249013
2007-10-25

Collections of Traceable Compounds and Uses Thereof

#46
20070248996
2007-10-25

Modulators of beta-amyloid peptide aggregation comprising D-amino acids

#47
20070224194
2007-09-27

Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis

#48
20060252698
2006-11-09

Compounds for inhibiting cathepsin activity

#49
20060241056
2006-10-26

Potent and specific immunoproteasome inhibitors

#50
20060228296
2006-10-12

Method of screening groups of radioactive molecules and applications thereof

#51
20060128613
2006-06-15

Melanocortin receptor ligands

#52
20060089312
2006-04-27

Smart pro-drugs of serine protease inhibitors

#53
20060083685
2006-04-20

Opioid metallopeptide compositions and methods

#54
20060014696
2006-01-19

Modulators of β-amyloid peptide aggregation comprising D-amino acids

#55
20060014695
2006-01-19

Hpma-polyamine conjugates and uses therefore

#56
20060003386
2006-01-05

Method of making metallopeptides

#57
20050272664
2005-12-08

Methods for inhibiting angiogenesis and or lymphangiogenesis

#58
20050220801
2005-10-06

Immunopotentiators

#59
20050215468
2005-09-29

Metal-binding compounds and uses therefor

#60
20050209146
2005-09-22

Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy

#61
20050181447
2005-08-18

Opioid metallopeptide compositions and methods

#62
20050159359
2005-07-21

Methods and compositions for derepression of IAP-inhibited caspase

#63
20050137139
2005-06-23

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#64
20050119176
2005-06-02

Methods and compositions for derepression of IAP-inhibited caspase

#65
20050038230
2005-02-17

Linear and cyclic melanocortin receptor-specific peptides